{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"ORBITA-2 &amp; PCI In Older Adults; Smartwatches and AFib Detection; Improved Management and Treatment of HF and HFrFF","description":" In this week\u2019s View, Dr. Eagle\u202flooks at&amp;nbsp;the ORBITA-2 trial&amp;nbsp;and how&amp;nbsp;percutaneous coronary intervention&amp;nbsp;(PCI)&amp;nbsp;may lead to greater&amp;nbsp;symptom relief in older adults.\u202fHe then\u202fexplores\u202fthe\u202fEQUAL&amp;nbsp;trial&amp;nbsp;that investigated&amp;nbsp;how&amp;nbsp;Apple&amp;nbsp;smartwatch monitoring improves&amp;nbsp;atrial fibrillation&amp;nbsp;(AFib)&amp;nbsp;detection.&amp;nbsp;Finally,\u202fDr. Eagle&amp;nbsp;examines&amp;nbsp;revelations&amp;nbsp;from the\u202fEMPEROR-Preserved\u202ftrial&amp;nbsp;regarding&amp;nbsp;interaction&amp;nbsp;between&amp;nbsp;SGLT2 inhibitors&amp;nbsp;and&amp;nbsp;baseline&amp;nbsp;magnesium&amp;nbsp;levels in&amp;nbsp;treating&amp;nbsp;patients&amp;nbsp;who have either&amp;nbsp;heart failure (HF)&amp;nbsp;or&amp;nbsp;HF with preserved&amp;nbsp;ejection fraction (HFpEF).&amp;nbsp;   \u202fSubscribe to Eagle\u2019s Eye View\u202f\u202f&amp;nbsp;  ","author_name":"Eagle's Eye View: Your Weekly CV Update From ACC.org","author_url":"http:\/\/www.acc.org","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/39981550\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/198191490"}